Company intelligence / Profile preview

NuRx Pharmaceuticals

San Francisco, California, United Statessec.gov ↗

Ownership: Private
Employees: ~2
Development stage: Phase 2

Overview

Nurx provides telehealth services for various health concerns including birth control, mental health, skincare, and more. The company merged with Thirty Madison in February 2022.

Therapeutic areas: PsychiatryEndocrinologyDermatologyWomen's HealthNeurologyInfectious Diseases
Industry: Non-Academic Healthcare

Drug pipeline

2 assets

VTP-195183

Phase 1

Indications: Acute myeloid leukemia, Acute promyelocytic leukemia

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on NuRx Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuRx Pharmaceuticals.

Explore the full profile